Medical News

RSS

Key mechanisms for delivery of LNP-encapsulated siRNAs to the liver

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of pre-clinical research in the journal Molecular Therapy revealing key mechanisms related to the systemic delivery of RNAi therapeutics using lipid nanoparticles (LNPs).

12 May 2010

MRSA Survivors Network to raise awareness on MRSA infections

More Americans die annually from invasive methicillin-resistant Staphylococcus aureus infections than from HIV/AIDS, H1N1 influenza and Parkinson's disease, yet the United States and many other countries' health officials continue to ignore the global crisis.

12 May 2010

Updated data from Vical's Phase 2 trial of high-dose Allovectin-7 in metastatic melanoma patients

Vical Incorporated announced the publication in the June issue of Melanoma Research of updated data from the company's Phase 2 trial of high-dose (2 mg) Allovectin-7® in patients with metastatic melanoma. A separate article in the May issue of Expert Opinion on Biological Therapy reviewed results from the Phase 2 trial and previous clinical studies of Allovectin-7®.

12 May 2010

MicroStockProfit.com releases investment report featuring Hemispherx Biopharma

MicroStockProfit.com announces an investment report featuring biopharmaceutical company Hemispherx Biopharma Inc. The report includes financial, comparative and investment analysis, and industry information you need to know to make an educated investment decision.

12 May 2010

TSO3 first-quarter net loss increases to $2,033,932

TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings using ozone, posted revenues of $144,228 for the sales of consumables and services for its first generation STERIZONE(R) Sterilizer (125L) for the first quarter ended March 31, 2010. This compares with $533,488 for the same period in the prior year in which three sterilizers (125L), consumables and services were sold.

12 May 2010

Mutations in STRAD-alpha gene can cause PMSE syndrome in Amish children: Penn researchers

So often the rare informs the common. Penn researchers investigating a regulatory protein involved in a rare genetic disease have shown that it may be related to epileptic and autistic symptoms in other more common neurological disorders.

12 May 2010

New approach to harness and modulate enzyme activity

An Arizona State University graduate student, Jinglin Fu, in collaboration with Biodesign Institute researchers Neal Woodbury and Stephen Albert Johnston, has pioneered a technique that improves on scientists' ability to harness and modulate enzyme activity.

12 May 2010

Older women want more information about breast cancer, breast screening: Survey

Most older women want more information about breast cancer and want to continue to be invited to breast screening, according to the results of a survey published in the British Journal of Cancer today.

12 May 2010

Giardia's surface proteins may work as vaccines to help prevent infections: Research scholar

The intestinal parasite Giardia lamblia changes outfits nearly as often as a fashion model on a Parisian runway. With more than 200 protein coats in its molecular wardrobe, this troublesome creature-the cause of innumerable cases of diarrheal infections each year-can change its appearance from one instant to the next, throwing the body's immune cells off track.

12 May 2010

Drug-releasing stents do not result in fewer deaths or subsequent heart attacks after angioplasty

Drug-releasing stents are more effective than bare metal stents at keeping a blocked artery open after angioplasty, but the difference does not result in fewer deaths or subsequent heart attacks after the procedure, according to a review of recent studies.

12 May 2010

Regenstrief Institute framework evaluates costs, effort and value of health internet

As the United States moves toward the goal of a secure nationwide health information network, a new study from the Regenstrief Institute provides a framework for evaluating the costs, effort and value of what is sometimes referred to as the health internet.

12 May 2010

Evotec first-quarter operating loss decreases 93% to € 1.5 m

Evotec AG today reported financial results and corporate updates for the first quarter of 2010.

12 May 2010

Preventable infectious diseases cause two-thirds of child deaths: The Lancet

Preventable infectious diseases cause two-thirds of child deaths, according to a new study published today by The Lancet. Experts from the World Health Organization and UNICEF's Child Health Epidemiology Reference Group assessed data from 193 countries to produce estimates by country, region and the world.

12 May 2010

Genetic tests represent future of cancer care for women

Important progress is being made in women's health through the use of genetic tests, particularly those that help women detect and treat cancer.

12 May 2010

Kallisto demonstrates major new version of BYOSYS solution at Orthopädie + Reha-Technik show

SensAble Technologies, Inc®, a leading provider of 3D modeling solutions and haptic devices, announced that its customer, Kallisto, a provider of 3D technologies as well as rapid prototyping and manufacturing solutions to the orthotics and prosthetics industry, is showcasing a major new version of its BYOSYS® solution at Europe's leading industry event, the Orthopädie + Reha-Technik show, which opened in Leipzig, Germany today.

12 May 2010

New report traces origins of 100 companies to federally funded university-based research

How can the United States foster long-term economic growth? A new report suggests that one of the best ways is through investment in the basic research that leads to innovation and job creation. "Sparking Economic Growth: How federally funded university research creates innovation, new companies and jobs" released today by The Science Coalition identifies 100 "success stories" - examples of companies that are the result of federal investments in basic research.

12 May 2010

COTI announces favourable independent pre-IND gap analysis report for novel oncology drug candidate

Critical Outcome Technologies Inc. announced today that it received a favourable Pre-Investigational New Drug (pre-IND) gap analysis report from an independent team that reviewed its novel oncology drug candidate COTI-2. This represents an important milestone as the Company draws closer to a Phase 1 clinical trial.

12 May 2010

Wheat aleurone contains high levels of potentially healthpromoting compounds

Wheat aleurone is a novel wheat grain fraction with high levels of potentially healthpromoting compounds. New clinical trials with ready-to-eat cereals and bread containing wheat aleurone have been performed, and showed increased blood concentrations of tentatively beneficial compounds such as betaine, and decreased homocysteine and LDL-cholesterol which are both associated with heart disease risk.

12 May 2010

CNP Assurances reports premium income of EUR9.4 billion for first-quarter 2010

CNP Assurances, the leading personal insurer in France, with operations in the rest of Europe and in South America, has announced its premium income and net profit figures for the first quarter of 2010.

12 May 2010

Mutation causing light chain amyloidosis identified

Light chain amyloidosis, a deadly protein misfolding disease, is caused by multiple mutations in cells that are intended to protect the body. Instead, the mutations send misfolded bundles of proteins through the bloodstream, potentially destroying the heart, kidneys, liver or other organs. Mayo Clinic researchers have identified one of these mutations and have shown that the molecule's shifting position is as important as its unique shape. The findings appear in the current issue of the journal Structure.

12 May 2010

Medical News

Key mechanisms for delivery of LNP-encapsulated siRNAs to the liver

MRSA Survivors Network to raise awareness on MRSA infections

Updated data from Vical's Phase 2 trial of high-dose Allovectin-7 in metastatic melanoma patients

MicroStockProfit.com releases investment report featuring Hemispherx Biopharma

TSO3 first-quarter net loss increases to $2,033,932

Mutations in STRAD-alpha gene can cause PMSE syndrome in Amish children: Penn researchers

New approach to harness and modulate enzyme activity

Older women want more information about breast cancer, breast screening: Survey

Giardia's surface proteins may work as vaccines to help prevent infections: Research scholar

Drug-releasing stents do not result in fewer deaths or subsequent heart attacks after angioplasty

Regenstrief Institute framework evaluates costs, effort and value of health internet

Evotec first-quarter operating loss decreases 93% to € 1.5 m

Preventable infectious diseases cause two-thirds of child deaths: The Lancet

Genetic tests represent future of cancer care for women

Kallisto demonstrates major new version of BYOSYS solution at Orthopädie + Reha-Technik show

New report traces origins of 100 companies to federally funded university-based research

COTI announces favourable independent pre-IND gap analysis report for novel oncology drug candidate

Wheat aleurone contains high levels of potentially healthpromoting compounds

CNP Assurances reports premium income of EUR9.4 billion for first-quarter 2010

Mutation causing light chain amyloidosis identified

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News